PRPO
Precipio, Inc.NASDAQHealthcare$27.90-2.11%ClosedMarket Cap: $49.8M
As of 2026-04-09
Valuation
P/E (TTM)
—
PEG
—
P/B
3.08
P/S
2.07
EV/EBITDA
32.41
DCF Value
$-304.84
FCF Yield
0.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
44.5%
Operating Margin
-5.0%
Net Margin
-1.5%
ROE
-2.8%
ROA
-1.7%
ROIC
-6.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $8.0M | 39.3% | $542.0K | $526.0K | $0.33 | — |
| FY 2025 | $24.0M | 44.5% | $-1.2M | $-363.0K | $-0.23 | — |
| Q3 2025 | $6.2M | 48.8% | $-61.0K | $-79.0K | $-0.05 | — |
| Q2 2025 | $5.7M | 43.0% | $-824.0K | $74.0K | $0.05 | — |
| Q1 2025 | $4.3M | 50.3% | $-859.0K | $-884.0K | $-0.59 | — |
| Q4 2024 | $5.5M | 48.6% | $-336.0K | $-365.0K | $-0.25 | — |
| FY 2024 | $16.0M | 47.3% | $-4.2M | $-4.3M | $-2.93 | — |
| Q3 2024 | $5.2M | 43.7% | $-597.0K | $-626.0K | $-0.42 | — |
| Q2 2024 | $4.4M | 32.0% | $-1.2M | $-1.2M | $-0.83 | — |
| Q1 2024 | $3.4M | 26.8% | $-2.1M | $-2.1M | $-1.46 | — |
| Q4 2023 | $4.3M | 46.5% | $-854.0K | $925.0K | $0.65 | — |
| FY 2023 | $15.2M | 39.6% | $-7.6M | $-5.9M | $-4.51 | — |